{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T01:40:06Z","timestamp":1751334006073,"version":"3.41.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,30]]},"DOI":"10.7759\/cureus.87068","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T01:21:11Z","timestamp":1751332871000},"source":"Crossref","is-referenced-by-count":0,"title":["Challenges in the Recognition and Management of Metastatic Sarcomatoid Carcinoma Masquerading As Post-traumatic Hematoma"],"prefix":"10.7759","author":[{"given":"Abigayle","family":"Wyer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mena","family":"Louis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Adams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raven","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ezra","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Gibson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.53565","article-title":"Sarcomatoid carcinoma: a clinicopathological dichotomy","volume":"16","author":"Ghosal R","year":"2024","unstructured":"Ghosal R, Roychowdhury D, Chatterjee RP, Sultana M, Sinha S. Sarcomatoid carcinoma: a clinicopathological dichotomy. Cureus. 2024, 16:e53565. 10.7759\/cureus.53565","journal-title":"Cureus"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cllc.2016.03.001","article-title":"Characteristics and clinical outcomes of sarcomatoid carcinoma of the lung","volume":"17","author":"Ung M","year":"2016","unstructured":"Ung M, Rouquette I, Filleron T, et al.. Characteristics and clinical outcomes of sarcomatoid carcinoma of the lung. Clin Lung Cancer. 2016, 17:391-397. 10.1016\/j.cllc.2016.03.001","journal-title":"Clin Lung Cancer"},{"key":"ref3","article-title":"Epidemiology of and prognostic factors for patients with sarcomatoid carcinoma: a large population-based study","volume":"10","author":"Xu Z","year":"2020","unstructured":"Xu Z, Wang L, Tu L, et al.. Epidemiology of and prognostic factors for patients with sarcomatoid carcinoma: a large population-based study. Am J Cancer Res. 2020, 10:3801-3814. 10(11):3801-3814.","journal-title":"Am J Cancer Res"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-019-6155-6","article-title":"Sarcomatoid carcinoma presenting as cancers of unknown primary: a clinicopathological portrait","volume":"19","author":"Huey RW","year":"2019","unstructured":"Huey RW, Makawita S, Xiao L, et al.. Sarcomatoid carcinoma presenting as cancers of unknown primary: a clinicopathological portrait. BMC Cancer. 2019, 19:965. 10.1186\/s12885-019-6155-6","journal-title":"BMC Cancer"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/jso.27433","article-title":"Metastatic sarcomatoid carcinoma to bone","volume":"128","author":"Sabharwal S","year":"2023","unstructured":"Sabharwal S, LiBrizzi CL, Wangsiricharoen S, Gross JM, Strike SA, Levin AS, Morris CD. Metastatic sarcomatoid carcinoma to bone. J Surg Oncol. 2023, 128:1446-1452. 10.1002\/jso.27433","journal-title":"J Surg Oncol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/cup.12998","article-title":"Metastatic sarcomatoid renal cell carcinoma manifesting as a subcutaneous soft tissue mass","volume":"44","author":"Logunova V","year":"2017","unstructured":"Logunova V, Sokumbi O, Iczkowski KA. Metastatic sarcomatoid renal cell carcinoma manifesting as a subcutaneous soft tissue mass. J Cutan Pathol. 2017, 44:874-877. 10.1111\/cup.12998","journal-title":"J Cutan Pathol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.clgc.2014.08.011","article-title":"Outcome of patients with metastatic sarcomatoid renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database Consortium","volume":"13","author":"Kyriakopoulos CE","year":"2015","unstructured":"Kyriakopoulos CE, Chittoria N, Choueiri TK, et al.. Outcome of patients with metastatic sarcomatoid renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database Consortium. Clin Genitourin Cancer. 2015, 13:e79-e85. 10.1016\/j.clgc.2014.08.011","journal-title":"Clin Genitourin Cancer"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.18.0000","article-title":"Metastatic sarcomatoid renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy","volume":"27","author":"Golshayan AR","year":"2009","unstructured":"Golshayan AR, George S, Heng DY, et al.. Metastatic sarcomatoid renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy. J Clin Oncol. 2009, 27:235-241. 10.1200\/JCO.2008.18.0000","journal-title":"J Clin Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2019.1606639","article-title":"Metastatic sarcomatoid renal cell carcinoma treated with immune checkpoint inhibitors","volume":"8","author":"Hanif A","year":"2019","unstructured":"Hanif A, Pandey M, Khan S, Attwood K, George S. Metastatic sarcomatoid renal cell carcinoma treated with immune checkpoint inhibitors. Oncoimmunology. 2019, 8:1606639. 10.1080\/2162402X.2019.1606639","journal-title":"Oncoimmunology"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1177\/1758835920950207","article-title":"Pulmonary sarcomatoid carcinoma: progress, treatment and expectations","volume":"12","author":"Li X","year":"2020","unstructured":"Li X, Wu D, Liu H, Chen J. Pulmonary sarcomatoid carcinoma: progress, treatment and expectations. Ther Adv Med Oncol. 2020, 12:10.1177\/1758835920950207","journal-title":"Ther Adv Med Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/PAP.0000000000000202","article-title":"Pulmonary sarcomatoid carcinomas: a review","volume":"25","author":"Weissferdt A","year":"2018","unstructured":"Weissferdt A. Pulmonary sarcomatoid carcinomas: a review. Adv Anat Pathol. 2018, 25:304-313. 10.1097\/PAP.0000000000000202","journal-title":"Adv Anat Pathol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.5858\/2008-0547-RAR.1","article-title":"Sarcomatoid carcinoma of the lung: histologic criteria and common lesions in the differential diagnosis","volume":"134","author":"Franks TJ","year":"2010","unstructured":"Franks TJ, Galvin JR. Sarcomatoid carcinoma of the lung: histologic criteria and common lesions in the differential diagnosis. Arch Pathol Lab Med. 2010, 134:49-54. 10.5858\/2008-0547-RAR.1","journal-title":"Arch Pathol Lab Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.21037\/tlcr-24-127","article-title":"Biological characteristics and clinical treatment of pulmonary sarcomatoid carcinoma: a narrative review","volume":"13","author":"Wei Y","year":"2024","unstructured":"Wei Y, Wang L, Jin Z, Jia Q, Brcic L, Akaba T, Chu Q. Biological characteristics and clinical treatment of pulmonary sarcomatoid carcinoma: a narrative review. Transl Lung Cancer Res. 2024, 13:635-653. 10.21037\/tlcr-24-127","journal-title":"Transl Lung Cancer Res"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1177\/15330338221109647","article-title":"The prognosis of pulmonary sarcomatoid carcinoma: development and validation of a nomogram based on SEER","volume":"21","author":"Xie Y","year":"2022","unstructured":"Xie Y, Lin Z, Shi H, Sun X, Gu L. The prognosis of pulmonary sarcomatoid carcinoma: development and validation of a nomogram based on SEER. Technol Cancer Res Treat. 2022, 21:10.1177\/15330338221109647","journal-title":"Technol Cancer Res Treat"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jss.2023.06.027","article-title":"Is sarcomatoid lung cancer associated with inferior overall survival? A National Cancer Database analysis","volume":"291","author":"Poston LM","year":"2023","unstructured":"Poston LM, Bassiri A, Jiang B, et al.. Is sarcomatoid lung cancer associated with inferior overall survival? A National Cancer Database analysis. J Surg Res. 2023, 291:380-387. 10.1016\/j.jss.2023.06.027","journal-title":"J Surg Res"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2020.01.014. Epub 2020 Jan 25.","article-title":"Efficacy of immune checkpoint inhibitors in lung sarcomatoid carcinoma","volume":"15","author":"Domblides C","year":"2020","unstructured":"Domblides C, Leroy K, Monnet I, et al.. Efficacy of immune checkpoint inhibitors in lung sarcomatoid carcinoma. J Thorac Oncol. 2020, 15:860-866. 10.1016\/j.jtho.2020.01.014. Epub 2020 Jan 25.","journal-title":"J Thorac Oncol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2015.10.009","article-title":"Clinical analysis of 95 cases of pulmonary sarcomatoid carcinoma","volume":"76","author":"Gu L","year":"2015","unstructured":"Gu L, Xu Y, Chen Z, Pan Y, Lu S. Clinical analysis of 95 cases of pulmonary sarcomatoid carcinoma. Biomed Pharmacother. 2015, 76:134-140. 10.1016\/j.biopha.2015.10.009","journal-title":"Biomed Pharmacother"},{"key":"ref18","article-title":"Pulmonary Sarcomatoid carcinoma: a surgical diagnosis and prognostic factors","volume":"97","author":"Smadhi H","year":"2019","unstructured":"Smadhi H, Boudaya MS, Abdannadher M, et al.. Pulmonary Sarcomatoid carcinoma: a surgical diagnosis and prognostic factors. Tunis Med. 2019, 97:128-132.","journal-title":"Tunis Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19920115)69:2<376::aid-cncr2820690218>3.0.co;2-u","article-title":"Sarcomatoid carcinoma of the lung. Immunohistochemical and ultrastructural studies of 14 cases","volume":"69","author":"Ro JY","year":"1992","unstructured":"Ro JY, Chen JL, Lee JS, Sahin AA, Ord\u00f3\u00f1ez NG, Ayala AG. Sarcomatoid carcinoma of the lung. Immunohistochemical and ultrastructural studies of 14 cases. Cancer. 1992, 69:376-386. 10.1002\/1097-0142(19920115)69:2&lt;376::aid-cncr2820690218&gt;3.0.co;2-u","journal-title":"Cancer"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.4143\/crt.2023.764","article-title":"Genomic landscape of pulmonary sarcomatoid carcinoma","volume":"56","author":"Kwon HJ","year":"2024","unstructured":"Kwon HJ, Lee S, Han YB, Lee J, Kwon S, Kim H, Chung JH. Genomic landscape of pulmonary sarcomatoid carcinoma. Cancer Res Treat. 2024, 56:442-454. 10.4143\/crt.2023.764","journal-title":"Cancer Res Treat"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jss.2017.05.065","article-title":"Long-term survival after resection of sarcomatoid carcinoma of the pancreas: an updated experience","volume":"219","author":"Blair AB","year":"2017","unstructured":"Blair AB, Burkhart RA, Griffin JF, et al.. Long-term survival after resection of sarcomatoid carcinoma of the pancreas: an updated experience. J Surg Res. 2017, 219:238-243. 10.1016\/j.jss.2017.05.065","journal-title":"J Surg Res"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19850601)55:11<2659::aid-cncr2820551122>3.0.co;2-q","article-title":"Preoperative, intraoperative, and postoperative radiation in the treatment of primary soft tissue sarcoma","volume":"55","author":"Suit HD","year":"1985","unstructured":"Suit HD, Mankin HJ, Wood WC, Proppe KH. Preoperative, intraoperative, and postoperative radiation in the treatment of primary soft tissue sarcoma. Cancer. 1985, 55:2659-2667. 10.1002\/1097-0142(19850601)55:11&lt;2659::aid-cncr2820551122&gt;3.0.co;2-q","journal-title":"Cancer"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2021-1071","article-title":"The treatment of advanced pulmonary sarcomatoid carcinoma","volume":"18","author":"Zheng Y","year":"2022","unstructured":"Zheng Y, Fu Y, Zhong Q, Deng R, Zhang Y. The treatment of advanced pulmonary sarcomatoid carcinoma. Future Oncol. 2022, 18:727-738. 10.2217\/fon-2021-1071","journal-title":"Future Oncol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1002\/pon.6240","article-title":"The psychological impact of sarcoma on affected patients","volume":"32","author":"Franzoi IG","year":"2023","unstructured":"Franzoi IG, Granieri A, Sauta MD, et al.. The psychological impact of sarcoma on affected patients. Psycho-Oncol. 2023, 32:1787-1797. 10.1002\/pon.6240","journal-title":"Psycho-Oncol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1099-1611(199703)6:1<65::Aid-pon236>3.0.Co;2-2","article-title":"A psychosocial intervention for patients with soft tissue sarcoma","volume":"6","author":"Payne DK","year":"1997","unstructured":"Payne DK, Lundberg JC, Brennan MF, Holland JC. A psychosocial intervention for patients with soft tissue sarcoma. Psycho-Oncol. 1997, 6:65-71. 10.1002\/(sici)1099-1611(199703)6:1&lt;65::Aid-pon236&gt;3.0.Co;2-2","journal-title":"Psycho-Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/374324-challenges-in-the-recognition-and-management-of-metastatic-sarcomatoid-carcinoma-masquerading-as-post-traumatic-hematoma","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T01:21:12Z","timestamp":1751332872000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/374324-challenges-in-the-recognition-and-management-of-metastatic-sarcomatoid-carcinoma-masquerading-as-post-traumatic-hematoma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,30]]},"references-count":25,"URL":"https:\/\/doi.org\/10.7759\/cureus.87068","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6,30]]}}}